Lv11
90 积分 2025-06-16 加入
Human peripheral blood mononuclear cells as a valuable source of disease‐related biomarkers: Evidence from comparative proteomics studies
1小时前
已完结
A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays
16天前
已完结
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
17天前
已完结
Cardio-Nephroprotection – the Most Important Goal of Antihypertensive Therapy in Patients With Type 2 Diabetes
23天前
已关闭
Free Drug Theory – No Longer Just a Hypothesis?
1个月前
已完结
A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies
1个月前
已完结
Drug Removal Strategies in Competitive Ligand Binding Neutralizing Antibody (NAb) Assays: Highly Drug-Tolerant Methods and Interpreting Immunogenicity Data
1个月前
已完结
Assay development considerations to improve drug tolerance in direct competitive ligand binding neutralizing antibody assays, pretreatment strategies
1个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
1个月前
已完结
皖公网安备34019202002308
